Source: Annual Congress 2010 - Colonisation and infection in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Quint, G. Donaldson, J. Goldring, R. Sapsford, J. Wedzicha (London, United Kingdom). Sputum and serum cytokine variability in frequent and infrequent exacerbators in stable COPD. Eur Respir J 2010; 36: Suppl. 54, 2890

Member's Comments

No comment yet.

Related content which might interest you: Frequent COPD exacerbators are not a stabile phenotype Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Comparison of small airways disease measures between frequent and infrequent COPD exacerbators Source: International Congress 2019 – Respiratory function assessment in disease Year: 2019 Ex-smokers with frequent COPD exacerbations have low FENO in stable condition Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Blood vs sputum eosinophils as predictors of exacerbations in a cohort of severe asthmatics Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018 Il-6 levels in sera and induced sputum of COPD patients during exacerbations and stable period Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Sputum biomarkers in stable COPD Source: Annual Congress 2011 - New mechanisms in airway disease Year: 2011 A high-risk airway mycobiome characterises frequent COPD exacerbators Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020 Cellular inflammatory pattern in induced sputum among patients with stable moderate or severe asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010 Common and atypical pathogens in severe COPD exacerbations and predictors of positive sputum cultures Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Inflammatory serum profiles are consistent across independent exacerbations in COPD patients with a history of frequent exacerbations Source: International Congress 2015 – COPD: interesting notes Year: 2015 Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Characteristic of cytokines levels of blood and sputum in COPD exacerbation Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Exacerbation phenotypes of frequent versus non-frequent exacerbators among severe asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD Source: Eur Respir J 2012; 40: 1344-1353 Year: 2012 Cytokine profile of blood and sputum at infectional COPD exacerbation Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD Year: 2008 Factors associated with sputum purulence in stable moderate to severe COPD patients Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 Frequent exacerbators among patients with COPD - prevalence and stability Source: International Congress 2017 – Markers of COPD progression Year: 2017 Association of the severe, frequent exacerbation phenotype with exercise capacity, sputum bacteriology and copeptin circulating levels in COPD Source: Annual Congress 2011 - Diagnosis and predictors of COPD exacerbation Year: 2011 Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017